Olema Pharmaceuticals (OLMA) Retained Earnings (2020 - 2026)
Olema Pharmaceuticals (OLMA) reported Retained Earnings of -$460000.0 for Q1 2026, down 209.52% year-over-year from $420000.0 in Q1 2025, and down 174.07% quarter-over-quarter from $621000.0 in Q4 2025.
Olema Pharmaceuticals (OLMA) Retained Earnings (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of Retained Earnings data on file, last reported at -$460000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$460000.0, down 209.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$460000.0 (down 209.52% YoY), and the FY2025 annual result was $621000.0, up 100.14% from the prior year.
- Retained Earnings declined to -$460000.0 in Q1 2026 per OLMA's latest filing, from $621000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $621000.0 in Q4 2025 and troughed at -$435.1 million in Q4 2024.
- A 5-year average of -$112.5 million and a median of -$518000.0 in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 1143314.29% in 2022, then surged 4300.0% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$1.8 million in 2022, then soared by 119.14% to $347000.0 in 2023, then plunged by 125490.78% to -$435.1 million in 2024, then jumped by 100.14% to $621000.0 in 2025, then plunged by 174.07% to -$460000.0 in 2026.
- Business Quant data shows OLMA's Retained Earnings at -$460000.0 in Q1 2026, $621000.0 in Q4 2025, and $526000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - | -460,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -460,000.00 |
| Dec 31, 2025 | 621,000.00 |
| Sep 30, 2025 | 526,000.00 |
| Jun 30, 2025 | 314,000.00 |
| Mar 31, 2025 | 420,000.00 |
| Dec 31, 2024 | -435.11 Mn |
| Sep 30, 2024 | -401.54 Mn |
| Jun 30, 2024 | -366.98 Mn |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | 347,000.00 |
| Sep 30, 2023 | -241,000.00 |
| Jun 30, 2023 | -518,000.00 |
| Mar 31, 2023 | -237.26 Mn |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | -182.80 Mn |
| Jun 30, 2022 | -160.08 Mn |
| Mar 31, 2022 | -127.22 Mn |
| Dec 31, 2021 | -104.19 Mn |
| Sep 30, 2021 | -82.55 Mn |
| Jun 30, 2021 | -14,000.00 |